InvestorsHub Logo

sleekscape

05/06/19 11:42 AM

#16042 RE: sleekscape #16041

Looks like CANB is going all in on SAM

It must be selling very well for them to increase supply by 300%

Things are about to get very interesting around here


DD ON SAM

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146492764


POTENTIAL SAM ANNUAL RUNNING REVENUES END 2019 = $23.5M

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146471160


MUST LISTEN INTERVIEW WITH CANB ON SAM

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146471411


CANB NEWS ON SAM UNITS

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147001104


Sleek

mr slam

05/08/19 4:12 AM

#16074 RE: sleekscape #16041


Canbiola Appoints David Woycik, Jr. to its Corporate Advisory Board and Completes a 300% Increased Investment in its Duramed Division to Combat the Opioid Crisis

Sleek- dead on observation here- Attny Woycik is a widely respected New York attorney with strong connections in the veterans arena, as well as pharma and governmental connections! Great great appointment!


The ramp up on SAM units is indicative of demand outpacing supply- as word spreads of the efficacy and benefit of this unit demand will continue to increase- again, an exponential money making machine-

Insurance payments have a tendency to lag invoice by 30, 60 , 90 days....

Revenue from SAM units being put in place will be staggered much like receivables on insurance billing cycles- the reality is, insurance companies PAY! Especially when there is promoted healing and reduction in narcotic prescriptions- HUGE HUGE HUGE!

With Peace and Love!

GO CANB!